"10.1371_journal.pone.0023433","plos one","2011-08-24T00:00:00Z","Igor Kraev; Christian Henneberger; Clara Rossetti; Lisa Conboy; Lene B Kohler; Martina Fantin; Alistair Jennings; Cesar Venero; Victor Popov; Dmitri Rusakov; Michael G Stewart; Elisabeth Bock; Vladimir Berezin; Carmen Sandi","Department of Life Sciences, The Open University, Milton Keynes, United Kingdom; Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London (UCL), London, United Kingdom; Laboratory of Behavioral Genetics, Brain Mind Institute, EPFL, Lausanne, Switzerland; Protein Laboratory, Department of Neuroscience and Pharmacology, Panum Institute, University of Copenhagen, Copenhagen, Denmark; Department of Psychobiology, UNED, Ciudad Universitaria, Madrid, Spain","Conceived and designed the experiments: CS. Performed the experiments: IK CH CR LC LBK AJ CV MF. Analyzed the data: IK CH CR LC LBK AJ CV MF VP DR MGS EB VB. Contributed reagents/materials/analysis tools: EB VB. Wrote the paper: CS.","E. Bock and V. Berezin are shareholders of ENKAM Pharmaceuticals A/S, which owns the plannexin peptide (less than 0.01% shares each). All other authors declare not having relevant financial or competing interests. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.",NA,NA,NA,"2011","08","Igor Kraev","IK",14,TRUE,1,8,13,1,TRUE,TRUE,FALSE,0,NA,FALSE
